Contact MD/TB-500 | TB-500 Research Editorial Feedback

Contact the Editorial Team

MD/TB-500 publishes summaries of the peer-reviewed research literature on TB-500 and thymosin beta-4. This is an editorial project — not a clinic, not a vendor, not a prescription service.

We accept the following types of correspondence:

Citation corrections. If you identify an error in a citation — incorrect PMID, incorrect DOI, misattributed finding — please send the corrected reference with the PubMed or journal URL. We update the literature record promptly.

Research updates. If a new study relevant to TB-500 or thymosin beta-4 has been published, we welcome notification with the DOI or PubMed link. We do not accept manuscripts for review and we do not provide peer review services.

General editorial feedback. Factual corrections, readability feedback, or questions about our editorial methodology are welcome.

We do not respond to: requests for medical advice, dosing recommendations, supplier referrals, or vendor partnership inquiries. No clinical consultation services are offered or implied by this publication.

Use the form below to send a message. We aim to respond to substantive editorial correspondence within five business days. Responses to clinical or vendor inquiries are not provided.